Halodine develops nasal and oral antiseptics that inactivate SARS-CoV-2 within 15 seconds, providing up to four hours of antiviral protection. Their products are designed to reduce the transmission of COVID-19 by sanitizing the nose and mouth, making them suitable for both adults and children.
Funding
$4.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The SARS-CoV-2 virus spreads through the nose and mouth, and traditional preventative measures like hand sanitizer do not address this primary route of transmission. This leaves individuals vulnerable to infection, especially in high-risk environments such as workplaces, schools, and sporting events. Current methods may not provide sufficient protection or convenience for widespread adoption.
Solution
Halodine develops nasal and oral antiseptic products designed to inactivate SARS-CoV-2 and other viruses in the nasal and oral cavities. These antiseptics provide a protective barrier, reducing the risk of viral transmission for up to four hours after application. The products are formulated for ease of use, with options including swab applicators and oral rinses suitable for both adults and children. By sanitizing the nose and mouth, Halodine offers an additional layer of protection against viral spread, complementing existing hygiene practices. The company aims to help individuals and organizations safely return to work, school, and other activities by minimizing the risk of infection.
Target Audience
The primary target audience includes individuals seeking to reduce their risk of contracting or spreading SARS-CoV-2, as well as organizations such as schools, workplaces, and sports leagues aiming to create safer environments.
Features
- Nasal antiseptic available in various formats: swabsticks, sprays, and multi-dose bottles
- Oral rinse formulation for sanitizing the mouth
- Rapid inactivation of SARS-CoV-2 within 15 seconds, as demonstrated in laboratory testing
- Provides up to four hours of antiviral protection after a single application
- Safe for use in both adults and children
- Easy-to-use applicators and formulations for convenient on-the-go use